Embecta Stock Gains on FDA Clearance for Type 2 Diabetes Insulin Pump
EMBC's shares close higher following FDA clearance for its disposable patch pump for insulin delivery, expanding the target market with its availability for type 2 diabetes.
| Ticker |
Sentiment |
Impact |
|
APYX
|
Neutral
|
11 %
|
|
EMBC
|
Bullish
|
51 %
|
|
UHS
|
Somewhat Bullish
|
27 %
|
|
BSX
|
Neutral
|
16 %
|
|
BDX
|
Somewhat Bullish
|
5 %
|
